Chugai Pharmaceutical Co., Ltd.

MUN:CUP0 Stock Report

Market Cap: €68.8b

Chugai Pharmaceutical Future Growth

Future criteria checks 1/6

Chugai Pharmaceutical is forecast to grow earnings and revenue by 5% and 3.8% per annum respectively. EPS is expected to grow by 5% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

5.0%

Earnings growth rate

5.0%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate3.8%
Future return on equity16.8%
Analyst coverage

Good

Last updated26 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

MUN:CUP0 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,219,135417,308366,354426,90013
12/31/20251,154,127385,457350,251415,91715
12/31/20241,127,709371,478365,336410,33414
9/30/20241,142,350386,964349,884419,416N/A
6/30/20241,084,570355,041265,465327,068N/A
3/31/20241,036,076326,373323,991383,090N/A
12/31/20231,111,367325,472350,827409,925N/A
9/30/20231,276,051336,745205,825258,712N/A
6/30/20231,243,437326,969200,169252,605N/A
3/31/20231,211,632316,154252,376299,319N/A
12/31/20221,259,946374,429172,873244,112N/A
9/30/20221,143,716370,791298,989366,072N/A
6/30/20221,205,696389,011339,236422,551N/A
3/31/20221,191,496387,359227,919305,626N/A
12/31/2021999,759302,995206,760279,626N/A
9/30/2021887,919256,462180,866256,890N/A
6/30/2021809,055230,577194,361252,664N/A
3/31/2021776,339210,611165,601246,567N/A
12/31/2020786,946214,733143,646205,035N/A
9/30/2020753,853202,590127,482211,422N/A
6/30/2020734,019190,599108,080196,718N/A
3/31/2020711,320174,062116,245178,610N/A
12/31/2019686,184157,560145,464206,641N/A
9/30/2019662,198139,54383,362160,274N/A
6/30/2019614,949113,07043,280118,955N/A
3/31/2019586,64899,63123,827101,309N/A
12/31/2018579,78792,48841,403119,074N/A
9/30/2018572,99485,85791,950125,700N/A
6/30/2018566,54885,285N/A120,997N/A
3/31/2018556,15982,101N/A127,695N/A
12/31/2017534,19972,713N/A107,623N/A
9/30/2017517,90867,704N/A63,732N/A
6/30/2017497,02358,143N/A67,355N/A
3/31/2017497,35457,592N/A49,230N/A
12/31/2016491,78053,592N/A38,787N/A
9/30/2016492,58456,562N/A40,808N/A
6/30/2016506,19262,537N/A39,670N/A
3/31/2016501,64961,043N/A49,913N/A
12/31/2015498,83961,125N/A62,918N/A
9/30/2015495,45558,897N/A75,502N/A
6/30/2015479,26552,220N/A50,719N/A
3/31/2015454,14746,786N/A54,919N/A
12/31/2014461,10950,980N/A37,034N/A
9/30/2014450,54552,461N/A38,017N/A
6/30/2014444,65855,044N/A60,556N/A
3/31/2014457,28160,774N/A54,886N/A
12/31/2013423,65250,895N/A53,521N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CUP0's forecast earnings growth (5% per year) is above the savings rate (0.8%).

Earnings vs Market: CUP0's earnings (5% per year) are forecast to grow slower than the German market (20.2% per year).

High Growth Earnings: CUP0's earnings are forecast to grow, but not significantly.

Revenue vs Market: CUP0's revenue (3.8% per year) is forecast to grow slower than the German market (5.5% per year).

High Growth Revenue: CUP0's revenue (3.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CUP0's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y